Please Wait
Applying Filters...
menu
    • menu
    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Reldesemtiv

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 316,957Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cytokinetics’ pipeline tumble persists after ALS med flops
    Cytokinetics’ pipeline tumble persists after ALS med flops

    01 Apr 2023

    // Max Bayer FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/cytokinetics-pipeline-tumble-continues-after-als-med-flops-phase-3-interim-look

    Max Bayer FIERCE BIOTECH
    01 Apr 2023
    Share Share
    Cytokinetics' Astellas-partnered ALS drug misses goal in phase 2
    Cytokinetics' Astellas-partnered ALS drug misses goal in phase 2

    07 May 2019

    // Nick P. Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/cytokinetics-astellas-partnered-als-drug-misses-goal-phase-2

    Nick P. Taylor FIERCE BIOTECH
    07 May 2019
    Share Share
    Solid Bio back in business after the FDA lifts hold on DMD gene therapy
    Solid Bio back in business after the FDA lifts hold on DMD gene therapy

    18 Jun 2018

    // John Carroll ENDPTS

    https://endpts.com/solid-bio-is-back-in-business-after-the-fda-lifts-clinical-hold-on-duchenne-md-gene-therapy/

    John Carroll ENDPTS
    18 Jun 2018
    Share Share